Taligen CEO recognized with Mass High Tech 2010 All-Star Award

NewsGuard 100/100 Score
Oct 30 2010

Taligen Therapeutics, a biotechnology company developing therapies that regulate the complement system to treat inflammatory and immune diseases, announced today that Abbie Celniker, Ph.D., CEO of Taligen Therapeutics was among the recipients of the Mass High Tech, Voice of New England Innovation, 2010 All-Star Awards. The All-Star Awards recognize 16 dynamic and influential leaders of New England's innovation economy. This is the 15th year of the awards program.

"I am honored to have received this recognition by Mass High Tech. The local biotechnology industry has long been a key contributor to economic growth in our community. Based on my recent interactions with the Mass Life Sciences Center and the Massachusetts Biotechnology Council, I believe now more than ever, that biotechnology will continue to accelerate innovation and drive employment in New England for the foreseeable future," said Abbie Celniker, Ph.D., President and CEO of Taligen Therapeutics.

Source:

 Taligen Therapeutics

Posted in: Device / Technology News | Healthcare News

Tags: , ,

Comments (0)

Suggested Reading

Exonate appoints Dr Rafiq Hasan as Non-Executive Director
Refeyn announces appointment of Fiona Coats as Chief Marketing Officer
Insilico Medicine's leadership to address key challenges in AI drug discovery at BIO Convention
Genes and age reveal new insights into cognitive variability, study finds
Non-viral gene therapy offers hope for chronic low back pain sufferers
New antibiotic lolamicin shows promise in fighting drug-resistant infections
Insilico and NVIDIA unveil new LLM transformer for solving biological and chemical tasks
Why use light scattering to analyze proteins and viral vectors?

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback

You might also like...
H.E.L Group extends sales and support with appointment of specialist distributors